IP Library Granted Patent US 10,004,859
Granted Patent B2
US 10,004,859 · App. 14/399,740 · Granted Jun 26, 2018

Atomizer

Inventors: Robert Gerhard Winkler (Aschaffenburg, DE); Herbert Wachtel (Ingelheim am Rhein, DE); Stephen Terence Dunne (Ipswich, GB); Andree Jung (Idar-Oberstein, DE)
Assignee: Boehringer Ingelheim International GmbH
A61M15/009A61M11/002A61M11/02A61M11/041A61M15/002A61M15/0021A61M15/0025A61M15/0035A61M15/0043A61M15/0045A61M15/0051A61M15/0055A61M15/0086A61M16/109A61M2016/0015A61M2016/0039A61M2202/064A61M2205/8225
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 10,004,859
App. No.
14/399,740
Granted
Jun 26, 2018
Kind
B2
Abstract

The invention relates to an apparatus for nebulizing preferably powdered medicinal formulations, the nebulization being assisted by propellant. According to the invention, the propellant is supplied in pulsed form to the powder cavity ( 1 ) containing the formulation, which is attached to the nozzle ( 3 ) from which the aerosol is emitted. The apparatus according to the invention provides an increase in the fraction of pulmonary particles in the aerosol leaving the nozzle ( 3 ).

Claims (35)

1. An apparatus for nebulising powdered medicinal formulation, wherein the nebulisation is assisted by a propellant which is supplied to a cavity in which is contained a measured amount of the powdered medicinal formulation, characterised in that the apparatus comprises

a device which has an inlet at which propellant is present, and through which the propellant can be conveyed, said device causing such flow characteristics in the propellant as it passes through that it exits the device in the form of a plurality of successive pulses or bursts which are kept distinct from one another and is supplied to the cavity in the form of a plurality of successive pulses or bursts which are kept distinct from one another; and

a dosing valve producing a single dose of the propellant upstream of the device and delivering the single dose of the propellant to the device such that the single dose of the propellant is converted into the plurality of successive pulses or bursts of propellant, which ejects a single dose of the powdered medicinal formulation from the apparatus to the patient within a time interval which corresponds to a time a patient draws breath,

wherein during the operation of the apparatus the device produces relatively low duty cycle pulses in which each pulse has a relatively short on-time where the pressure is relatively high followed by a relatively long off-time where the pressure is permitted to fall to or near zero.

2. The apparatus according to claim 1 , characterised in that the pulses or bursts are kept distinct from one another such that the flow of propellant comes to a standstill between the pulses and/or the pressure of the propellant leaving the device falls to zero or virtually zero.

3. The apparatus according to claim 1 , characterised in that the propellant is stored in the form of liquefied propellant gas in a container or a cartridge ( 5 ), the apparatus having a metering valve for removing a measured volume of propellant from the container or the cartridge ( 5 ) and the device being located downstream of the metering valve.

4. The apparatus according to claim 3 , characterised in that the device generates the pulses in the propellant such that the measured volume of propellant is divided into pulses or bursts in such a way that the division of the measured volume into pulses or bursts corresponds to a distribution of 100 microliters between at least 7 pulses or bursts.

5. The apparatus according to claim 1 , characterised in that the propellant is supplied through a valve which divides the propellant present into a plurality of pulses by means of a plurality of opening and closing processes.

6. The apparatus according to claim 5 , characterised in that the valve is an actuatable magnetic valve ( 13 ).

7. The apparatus according to claim 5 , characterised in that during the operation of the apparatus the valve has opening times in the range from 3 to 30 milliseconds, and closure times in the range from 60 to 500 milliseconds.

8. The apparatus according to claim 1 , characterised in that the propellant is supplied through a channel structure forming a microfluidic oscillator in which the pulses or bursts are produced in the propellant.

9. The apparatus according to claim 8 , characterised in that the channel structure comprises at least one fork and a mixing region for fluid jets.

10. The apparatus according to claim 1 , characterised in that before being fed into the cavity the propellant is passed through a vaporiser ( 6 ) or heat exchanger.

11. The apparatus according to claim 10 , characterised in that the vaporiser ( 6 ) has a cavity ( 9 a ) and contains in its cavity ( 9 a ) one or more heat exchange elements.

12. The apparatus according to claim 11 , characterised in that metal beads and/or metal wires form the heat exchange element or the heat exchange elements.

13. The apparatus according to claim 1 , characterised in that a propellant stream charged with powdered medicinal formulation is conveyed from the cavity into a nozzle ( 3 ) and the nozzle ( 3 ) comprises a substantially rectilinear nozzle channel ( 3 a ).

14. The apparatus according to claim 13 , characterised in that the feed line for propellant into the cavity and the axis through the nozzle channel ( 3 a ) both meet at an angle of between 30° and 45° in the cavity and/or at this angle relative to the base of the cavity.

15. The apparatus according to claim 13 , characterised in that the nozzle channel ( 3 a ) comprises an inlet cone ( 3 b ) and/or an outlet cone ( 3 c ) and/or a wall of the nozzle channel ( 3 a ) is cylindrical, at least in a central region.

16. The apparatus according to claim 13 , characterised in that the cavity in which a measured amount of the powdered medicinal formulation is contained in a powder cavity ( 1 ) which is streamlined in shape.

17. The apparatus according to claim 16 , characterised in that the powder cavity ( 1 ) has a teardrop shape, a narrower end of the teardrop shape pointing in a direction of an inlet of the nozzle channel ( 3 a ).

18. The apparatus according to claim 16 , characterised in that the powder cavity ( 1 ) has a powder cavity well ( 1 a ), which has a slope ( 1 c ) on a bottom of the powder cavity well ( 1 a ), this slope ( 1 c ) conveying the flow in the direction of the inlet of the nozzle channel ( 3 a ).

19. A method for nebulising powdered medicinal formulations, comprising:

supplying a propellant in the form of a plurality of successive pulses or bursts distinct from one another, to a cavity in which there is a measured amount of the powdered medicinal formulation,

wherein the propellant is supplied through a channel structure forming a microfluidic oscillator in which the pulses or bursts are produced in the propellant.

20. An apparatus for nebulising powdered medicinal formulation, wherein the nebulisation is assisted by a propellant which is supplied to a cavity in which is contained a measured amount of the powdered medicinal formulation, wherein

the apparatus comprises a device which has an inlet at which propellant is present, and through which the propellant can be conveyed, said device causing such flow characteristics in the propellant as it passes through that it exits the device in the form of a plurality of successive pulses or bursts which are kept distinct from one another and is supplied to the cavity in the form of a plurality of successive pulses or bursts which are kept distinct from one another, and

the propellant is supplied through a channel structure forming a microfluidic oscillator in which the pulses or bursts are produced in the propellant.

21. An apparatus for nebulising powdered medicinal formulation, wherein the nebulisation is assisted by a propellant which is supplied to a cavity in which is contained a measured amount of the powdered medicinal formulation,

wherein the apparatus comprises a device which has an inlet at which propellant is present, and through which the propellant can be conveyed, said device causing such flow characteristics in the propellant as it passes through that it exits the device in the form of a plurality of successive pulses or bursts which are kept distinct from one another and is supplied to the cavity in the form of a plurality of successive pulses or bursts which are kept distinct from one another, and

wherein during the operation of the apparatus the device produces relatively low duty cycle pulses in which each pulse has a relatively short on-time where the pressure is relatively high followed by a relatively long off-time where the pressure is permitted to fall to or near zero.

22. The apparatus of claim 21 , wherein the on-time is in the range from 3 to 30 milliseconds, and the off-time is in the range from 60 to 500 milliseconds.

23. An apparatus for nebulising powdered medicinal formulation, wherein the nebulisation is assisted by a propellant which is supplied to a cavity in which is contained a measured amount of the powdered medicinal formulation,

wherein the apparatus comprises a device which has an inlet at which propellant is present, and through which the propellant can be conveyed, said device causing such flow characteristics in the propellant as it passes through that it exits the device in the form of a plurality of successive pulses or bursts which are kept distinct from one another and is supplied to the cavity in the form of a plurality of successive pulses or bursts which are kept distinct from one another,

wherein a propellant stream charged with powdered medicinal formulation is conveyed from the cavity into a nozzle ( 3 ) and the nozzle ( 3 ) comprises a substantially rectilinear nozzle channel ( 3 a ), and

wherein the feed line for propellant into the cavity and the axis through the nozzle channel ( 3 a ) both meet at an angle of between 30° and 45° in the cavity and/or at this angle relative to the base of the cavity.

Assignments (1)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Apr 9, 2015
From: WINKLER, ROBERT GERHARD; WACHTEL, HERBERT; DUNNE, STEPEHN TERENCE; JUNG, ANDREE
To: BOEHRINGER INGELHEIM INTERNATIONAL GMBH
Reel/Frame 035368/0023 →
Priority Claims (2)
EP 12167219 · May 9, 2012 · regional
EP 12190436 · Oct 29, 2012 · regional
Continuity (1)
Related Publication 20150122257A1 · May 7, 2015